GLOBEALERT
Business● Low19m ago · Nov 10, 2026, 7:32 PM

Autolus expects full-year 2026 AUCATZYL net product revenue at or above $150M, as BOBCAT data shifts to October 2027

GlobeAlert Desk · curated from Seeking Alpha Tech · global

Autolus anticipates net product revenue for AUCATZYL to be at least $150M in fiscal year 2026, while the release of BOBCAT data has been rescheduled to October 2027. This provides an update on the company's financial projections and development timeline.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level
0 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources
1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

Category
Business

Not flagged as developing.

More in Business